Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Neurodegenerative Diseases: from Mechanism to Medicine


for Members

Neurodegenerative Diseases: from Mechanism to Medicine

Friday, May 12, 2006

Harvard Medical School

Presented By

Presented by the Harvard Center for Neurodegeneration & Repair and the New York Academy of Sciences




8.45 – 9.00am


9.00 – 9.15

Welcome: Adrian Ivinson and Mike Wolfe

Session 1: Chair, Dennis Selkoe
9.15 – 10.00: Keynote Address: Steven Paul, "Apolipoprotein E Alleles and Alzheimer's Disease: Therapeutic Implications."
10.00 – 10.35: Karen Ashe, "Molecular Mechanisms of Memory Loss in Alzheimer Mouse Models."
10.35 – 11.10: Robert Brown, "How Motor Neurons Get Mutated, Get Wild, and Get a Life."

11.10 – 11.30: Break

Session 2: Chair, Cindy Lemere
11.30 – 12.05 pm: Ted Dawson, "Parkinson's Disease - Looking Forward: Tomorrow's Therapies."
12.05 – 12.40: Mike Wolfe, "Targeting γ-Secretase for Alzheimer's Disease."

12.40 – 2.00: Lunch

Session 3: Chair, Bruce Yankner
2.00 – 2.45: Keynote Address: Paul Greengard, "Regulation of Biosynthesis and Action on β-amyloid.”
2.45 – 3.00: Connie Cepko, "Photoreceptor Development and Disease.”
3.00 – 3.35: Reisa Sperling, "Neuroimaging and Novel Therapies for Alzheimer's Disease.”

3.35 – 3.50: Break

Session 4: Chair Marcie Glicksman
3.50 – 4.25: Peter Lansbury, "Therapeutic Approaches to Parkinson's Disease.”
4.25 – 5.00: Dale Schenk, "Abeta Immunotherapy: Support for the Amyloid Hypothesis."

5.00 – 6.00: Reception